Diana Torgersen, Shirin Heidari, Deana Mohr
Invent: Life Sciences – 25 October 2023
Throughout almost all of medical history, it was assumed that the average white male response to drug trials could be extrapolated to all potential recipients. But when we look at the poorer health outcomes for women and minorities, could the underlying assumptions in medical research be a contributing factor? If so, what is being done to solve them? Diana Torgersen, Shirin Heidari, and Deana Mohr were invited to share their thoughts on these questions.
Listen here: Life Sciences: Sex and Gender in Medical Research